Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SYF2
(
SYF2
homologue, RNA splicing factor), also known as
CCNDBP1-interactor
or p29, belongs to the
SYF2
family, which are involved in pre-mRNA splicing and cell cycle progression. Accumulating evidences demonstrate that
SYF2
exerted multiple effects including pro-apoptosis, cell differentiation, and glial activation in the pathogenesis of various experimental central nervous system (CNS) diseases. However,
SYF2
expression and functions in the retina are still with limited acquaintance. To investigate whether
SYF2
was involved in retinal degeneration, we performed a light-induced retinal damage model in adult rats. The
SYF2
protein expression was dramatically upregulated after retinal damage. Besides that,
SYF2
localized in the retinal ganglion cell (RGC) layer (GCL), inner unclear layer (INL), and outer nuclear layer (ONL) after light exposure. In addition, the expression of cyclin D1, CDK4, and active
caspase-3
was parallel with
SYF2
. We also found the co-localization of
SYF2
with active
caspase-3
, PCNA, and CD11b. Collectively,
SYF2
might participate in RGC apoptosis and retinal glia cell proliferation after light-induced retinal damage.
...
PMID:Upregulation of SYF2 Relates to Retinal Ganglion Cell Apoptosis and Retinal Glia Cell Proliferation After Light-Induced Retinal Damage. 2594 18